Note 3 - Revenue (Tables)

9 Months Ended

Sep. 30, 2023

Notes Tables

Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]

Balance outstanding at December 31, 2022	$	9,982
Increase (decrease) attributed to:
Amounts transferred over time to contract assets		76,225
Allowance for current expected credit losses		(22	)
Amounts invoiced during the period		(74,439	)
Balance outstanding at September 30, 2023	$	11,746

Disaggregation of Revenue [Table Text Block]

	Three Months Ended September 30, 2023
	Product/ Service Transferred Over Time		Product Transferred at Point in Time		Noncash Consideration		Total Net Sales by Market
Medical	$	12,029	$	5,185	$	621	$	17,835
Industrial		8,195		1,999		241		10,435
Aerospace and Defense		4,609		450		40		5,099
Total net sales	$	24,833	$	7,634	$	902	$	33,369

	Three Months Ended September 30, 2022
	Product/ Service Transferred Over Time		Product Transferred at Point in Time		Noncash Consideration		Total Net Sales by Market
Medical	$	14,753	$	5,366	$	420	$	20,539
Industrial		8,104		2,314		420		10,838
Aerospace and Defense		3,202		493		204		3,899
Total net sales	$	26,059	$	8,173	$	1,044	$	35,276

	Nine Months Ended September 30, 2023
	Product/ Service Transferred Over Time		Product Transferred at Point in Time		Noncash Consideration		Total Net Sales by Market
Medical	$	42,324	$	15,564	$	1,926	$	59,814
Industrial		21,378		6,532		1,056		28,966
Aerospace and Defense		12,523		1,674		301		14,498
Total net sales	$	76,225	$	23,770	$	3,283	$	103,278

	Nine Months Ended September 30, 2022
	Product/ Service Transferred Over Time		Product Transferred at Point in Time		Noncash Consideration		Total Net Sales by Market
Medical	$	37,725	$	15,044	$	1,574	$	54,343
Industrial		21,563		6,301		1,095		28,959
Aerospace and Defense		13,248		1,254		701		15,203
Total net sales	$	72,536	$	22,599	$	3,370	$	98,505